$300.0M
+$300.0M this year1 filing since 2026 · latest Equity filed
Verily Health is a precision health company that turns multimodal patient data into AI-driven insights for clinical care and research. Spun out of Alphabet in March 2026 with a $300 million round led by Series X Capital, it converted from an LLC to a corporation and now operates independently from a Dallas, Texas headquarters, with Alphabet remaining a minority investor. Its platform unifies fragmented health data across health systems and powers a product line spanning clinical research, population health monitoring, chronic care management and a consumer health app. Customers include health systems, life sciences organizations and research institutions; UCHealth and the University of Colorado Anschutz participated in the funding round.
What sets it apart
An AI-native platform that unifies fragmented, multimodal patient data across health systems into a single research- and care-grade layer, backed by more than a decade of Alphabet-scale investment in clinical, regulatory and data infrastructure.
An AI-native precision health platform that unifies fragmented patient data across health systems into a structured foundation for clinical and research applications.
